News

Graphite Bio divests gene editing pipeline to newly-formed Kamau Therapeutics after announcing reverse merger with Lenz Therapeutics

Kamau Therapeutics has emerged from stealth mode after inking a deal with Graphite Bio for its genome editing assets. Kamau’s debut comes less than a month after Graphite entered a reverse merger deal with Lenz […]

News

Ex-Cedilla CEO Glucksmann explores ‘new frontier’ at Sensorium; R&D chief out at Merck women’s health spinoff Organon

Alexandra Glucksmann Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her next pursuit is in mental health. The longtime […]

News

Camino Pharma receives $1.97M Small Business Innovation Research (SBIR) Grant from the National Institute of Alcohol Abuse and Alcoholism

New class of drugs focuses on alcohol use disorder SAN DIEGO, Dec. 7, 2023 /PRNewswire/ — Camino Pharma, LLC, a biotech company focused on finding cures for cancer and brain disorders, announced today that its […]